Skip to content

Effect of intervention on adherence in Diabetics

Development and evaluation a theory-based intervention for medication and diet adherence in Patients with Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151208025431N4
Enrollment
248
Registered
2018-03-10
Start date
2018-05-22
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabet. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Theory-based interventions based on HAPA and needs assessment baseline. Intervention 2: Control group: The control group will not intervene and only HbA1c Test we

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: Younger than 65 years Patients with diabetes referred to the health centers of the South under the cover of Tehran University of Medical Sciences whose disease has been confirmed by doctors. Diagnosed with type 2 diabetes for more than six months. They have Score of medication and diet adherence low. To be satisfied with the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Adherence scale of medication. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the intervention. Method of measurement: Morisky questionaire.;Adherence scale of diet. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the intervention. Method of measurement: questionaire.

Secondary

MeasureTime frame
Task selfefficacy. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Intention. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Action planning. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Coping planning. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Coping selfefficacy. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Recovery selfefficacy. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;Perceived social support. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 1, 6 months after the interven. Method of measurement: questionaire.;HbA1C. Timepoint: Adherence measurement at the beginning of the study (before the intervention) and 6 months after the interven. Method of measurement: HbA1C.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Ranjbaran

Tehran University of Medical Sciences

sph@tums.ac.ir+98 21 4293 3333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026